Average Co-Inventor Count = 4.52
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Csl Behring Ag (6 from 26 patents)
2. Csl Behring Gmbh (2 from 74 patents)
3. Universitât Bern (2 from 61 patents)
4. Universitaet Bern (2 from 8 patents)
5. Zlb Behring Ag (2 from 5 patents)
6. University of Washington (1 from 2,104 patents)
7. Beth Israel Deaconess Medical Center, Inc. (1 from 517 patents)
8. Zlb Bioplasma Ag (1 from 2 patents)
11 patents:
1. 10973891 - Treatment and prevention of remote ischemia-reperfusion injury
2. 10286047 - Treatment and prevention of remote ischemia-reperfusion injury
3. 10221233 - Compositions comprising secretory-like immunoglobulins
4. 9932392 - Prevention of infection
5. 9546209 - Treatment of mucositis with immunoglobulin
6. 9522184 - CD89 activation in therapy
7. 8632773 - Antibody composition with altered Fab sialylation
8. 7887797 - Immunoglobulin fractions
9. 7429647 - Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
10. 7399471 - Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
11. 7038020 - Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use